Post-earnings recap
Reported
Thu, May 7, 2020
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
Est. EPS
—
Est. Rev
—
Impl. Move
—
Collegium Pharmaceutical reported a small EPS of $0.01, which was significantly below expectations. Despite this miss, the stock rose by 3.57%, indicating that investors may have reacted positively to other aspects of the company's performance or outlook, although specific details are not available.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.01 | N/A | -96.86% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based on numerical results only.